CRISPR Therapeutics AG 10-K for FY2024
CRISPR Therapeutics AG (CRSP)
10-K
2025-02-11
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 11, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $37.31M
- down 89.9% from $371.21M a year earlier
- Net loss
- $366.25M
- compared with a net loss of $153.61M a year earlier
- Diluted EPS
- -$4.34
- compared with -$1.94 a year earlier